Translating the results of phase III randomized cancer trials into the language of physician obligation to patients Maurie Markman Editor’s Commentary Pages: 243 - 244
Adjuvant therapy for resected non-small-cell lung cancer: Recent advances, emerging agents, and lingering questions Tara L. LinJulie R. Brahmer OriginalPaper Pages: 251 - 258
Estrogen receptor pathways in lung cancer Laura P. StabileJill M. Siegfried OriginalPaper Pages: 259 - 267
Treatment options for small cell lung cancer Todd WolfHeidi H. Gillenwater OriginalPaper Pages: 268 - 271
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer Dawn HershmanRashmi Narayanan OriginalPaper Pages: 277 - 284
Management of hot flashes in breast cancer survivors and men with prostate cancer Vered Stearns OriginalPaper Pages: 285 - 290
Pain management, including intrathecal pumps Thomas J. SmithCraig SwaineyPatrick J. Coyne OriginalPaper Pages: 291 - 296
Role of gene expression arrays in sarcomas Keith M. SkubitzAmy P. N. Skubitz OriginalPaper Pages: 309 - 314
The role and limitations of radiofrequency ablation in treatment of bone and soft tissue tumors Kamran Ahrar OriginalPaper Pages: 315 - 320